• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表面活性剂蛋白 A 和 D:三聚体先天免疫蛋白,对病毒融合蛋白具有亲和力。

Surfactant Proteins A and D: Trimerized Innate Immunity Proteins with an Affinity for Viral Fusion Proteins.

机构信息

Child Health, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, United Kingdom.

Computational Chemistry, Chemistry, Faculty of Natural and Environmental Sciences, University of Southampton, Southampton, United Kingdom.

出版信息

J Innate Immun. 2019;11(1):13-28. doi: 10.1159/000492974. Epub 2018 Oct 5.

DOI:10.1159/000492974
PMID:30293076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6738215/
Abstract

Innate recognition of viruses is an essential part of the immune response to viral pathogens. This is integral to the maintenance of healthy lungs, which are free from infection and efficient at gaseous exchange. An important component of innate immunity for identifying viruses is the family of C-type collagen-containing lectins, also known as collectins. These secreted, soluble proteins are pattern recognition receptors (PRRs) which recognise pathogen-associated molecular patterns (PAMPs), including viral glycoproteins. These innate immune proteins are composed of trimerized units which oligomerise into higher-order structures and facilitate the clearance of viral pathogens through multiple mechanisms. Similarly, many viral surface proteins form trimeric configurations, despite not showing primary protein sequence similarities across the virus classes and families to which they belong. In this review, we discuss the role of the lung collectins, i.e., surfactant proteins A and D (SP-A and SP-D) in viral recognition. We focus particularly on the structural similarity and complementarity of these trimeric collectins with the trimeric viral fusion proteins with which, we hypothesise, they have elegantly co-evolved. Recombinant versions of these innate immune proteins may have therapeutic potential in a range of infectious and inflammatory lung diseases including anti-viral therapeutics.

摘要

先天识别病毒是对病毒病原体免疫反应的重要组成部分。这对于维持健康的肺部至关重要,肺部没有感染,气体交换效率高。识别病毒的先天免疫的一个重要组成部分是含有 C 型胶原蛋白的凝集素家族,也称为 collectins。这些分泌的可溶性蛋白质是模式识别受体 (PRR),可识别病原体相关的分子模式 (PAMP),包括病毒糖蛋白。这些先天免疫蛋白由三聚体单元组成,这些三聚体单元寡聚形成更高阶的结构,并通过多种机制促进清除病毒病原体。同样,许多病毒表面蛋白形成三聚体构象,尽管它们在所属的病毒类和科之间没有显示出主要的蛋白质序列相似性。在这篇综述中,我们讨论了肺 collectins(即表面活性剂蛋白 A 和 D (SP-A 和 SP-D))在病毒识别中的作用。我们特别关注这些三聚体 collectins 与三聚体病毒融合蛋白的结构相似性和互补性,我们假设它们与这些融合蛋白优雅地共同进化。这些先天免疫蛋白的重组版本可能在一系列感染和炎症性肺部疾病中具有治疗潜力,包括抗病毒治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/6738215/d1be6593dc3e/jin-0011-0013-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/6738215/4900cc4e39be/jin-0011-0013-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/6738215/af37e2a46ac1/jin-0011-0013-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/6738215/b63dd5755f29/jin-0011-0013-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/6738215/15f7e1c7e00f/jin-0011-0013-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/6738215/d1be6593dc3e/jin-0011-0013-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/6738215/4900cc4e39be/jin-0011-0013-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/6738215/af37e2a46ac1/jin-0011-0013-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/6738215/b63dd5755f29/jin-0011-0013-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/6738215/15f7e1c7e00f/jin-0011-0013-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a590/6738215/d1be6593dc3e/jin-0011-0013-g05.jpg

相似文献

1
Surfactant Proteins A and D: Trimerized Innate Immunity Proteins with an Affinity for Viral Fusion Proteins.表面活性剂蛋白 A 和 D:三聚体先天免疫蛋白,对病毒融合蛋白具有亲和力。
J Innate Immun. 2019;11(1):13-28. doi: 10.1159/000492974. Epub 2018 Oct 5.
2
Surfactant collectins and innate immunity.表面活性剂蛋白与固有免疫
Neonatology. 2008;93(4):288-94. doi: 10.1159/000121454. Epub 2008 Jun 5.
3
Collections and ficolins: humoral lectins of the innate immune defense.集落刺激因子和纤维胶凝蛋白:天然免疫防御的体液凝集素
Annu Rev Immunol. 2003;21:547-78. doi: 10.1146/annurev.immunol.21.120601.140954. Epub 2001 Dec 19.
4
Surfactant proteins SP-A and SP-D: structure, function and receptors.表面活性蛋白SP-A和SP-D:结构、功能与受体
Mol Immunol. 2006 Mar;43(9):1293-315. doi: 10.1016/j.molimm.2005.08.004. Epub 2005 Oct 5.
5
Protective role of the lung collectins surfactant protein A and surfactant protein D in airway inflammation.肺凝集素表面活性蛋白A和表面活性蛋白D在气道炎症中的保护作用。
J Allergy Clin Immunol. 2008 Nov;122(5):861-79; quiz 880-1. doi: 10.1016/j.jaci.2008.10.014.
6
Nucleic acid is a novel ligand for innate, immune pattern recognition collectins surfactant proteins A and D and mannose-binding lectin.核酸是一种新型配体,可与天然免疫模式识别凝集素表面活性蛋白A和D以及甘露糖结合凝集素结合。
J Biol Chem. 2004 Jul 30;279(31):32728-36. doi: 10.1074/jbc.M403763200. Epub 2004 May 15.
7
Lung surfactant proteins A and D as pattern recognition proteins.肺表面活性物质蛋白A和D作为模式识别蛋白。
Adv Exp Med Biol. 2009;653:74-97. doi: 10.1007/978-1-4419-0901-5_6.
8
Surfactant protein A and surfactant protein D variation in pulmonary disease.肺部疾病中表面活性蛋白A和表面活性蛋白D的变化
Immunobiology. 2007;212(4-5):381-416. doi: 10.1016/j.imbio.2007.01.003. Epub 2007 Feb 23.
9
Pulmonary collectins in innate immunity of the lung.肺部天然免疫中的肺凝集素
Cell Microbiol. 2007 Aug;9(8):1871-9. doi: 10.1111/j.1462-5822.2007.00953.x. Epub 2007 May 8.
10
Structure, genetics and function of the pulmonary associated surfactant proteins A and D: The extra-pulmonary role of these C type lectins.肺相关表面活性蛋白A和D的结构、遗传学与功能:这些C型凝集素在肺外的作用
Ann Anat. 2017 May;211:184-201. doi: 10.1016/j.aanat.2017.03.002. Epub 2017 Mar 27.

引用本文的文献

1
Pulmonary Delivery of Nonviral Nucleic Acid-Based Vaccines With Spotlight on Gold Nanoparticles.以金纳米颗粒为重点的非病毒核酸疫苗的肺部递送
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 Jan-Feb;17(1):e70000. doi: 10.1002/wnan.70000.
2
Immune Response to Respiratory Viral Infections.呼吸道病毒感染的免疫反应。
Int J Mol Sci. 2024 Jun 4;25(11):6178. doi: 10.3390/ijms25116178.
3
Human surfactant protein A inhibits SARS-CoV-2 infectivity and alleviates lung injury in a mouse infection model.人表面活性剂蛋白 A 抑制 SARS-CoV-2 感染性并减轻小鼠感染模型中的肺损伤。

本文引用的文献

1
Burden of antimicrobial resistance in an era of decreasing susceptibility.在抗菌药物敏感性降低的时代,抗菌药物耐药性的负担。
Expert Rev Anti Infect Ther. 2017 Jul;15(7):663-676. doi: 10.1080/14787210.2017.1337508. Epub 2017 Jun 13.
2
Airway proteases: an emerging drug target for influenza and other respiratory virus infections.气道蛋白酶:流感及其他呼吸道病毒感染的新兴药物靶点。
Curr Opin Virol. 2017 Jun;24:16-24. doi: 10.1016/j.coviro.2017.03.018. Epub 2017 Apr 14.
3
Novel expression of a functional trimeric fragment of human SP-A with efficacy in neutralisation of RSV.
Front Immunol. 2024 Mar 26;15:1370511. doi: 10.3389/fimmu.2024.1370511. eCollection 2024.
4
A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial).一项关于雾化表面活性剂治疗成人重症 COVID-19 的随机对照试验(COVSurf 试验)。
Sci Rep. 2023 Nov 28;13(1):20946. doi: 10.1038/s41598-023-47672-x.
5
Molecular Impact of Conventional and Electronic Cigarettes on Pulmonary Surfactant.常规和电子烟对肺表面活性剂的分子影响。
Int J Mol Sci. 2023 Jul 20;24(14):11702. doi: 10.3390/ijms241411702.
6
Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPD.多组学揭示慢性阻塞性肺疾病中全球表面活性剂失调与气流阻塞和肺气肿之间的联系。
ERJ Open Res. 2022 May 15;9(3). doi: 10.1183/23120541.00378-2022. eCollection 2023 May.
7
Single-cell profiling of vascular endothelial cells reveals progressive organ-specific vulnerabilities during obesity.单细胞分析血管内皮细胞揭示肥胖过程中器官特异性脆弱性的进展。
Nat Metab. 2022 Nov;4(11):1591-1610. doi: 10.1038/s42255-022-00674-x. Epub 2022 Nov 18.
8
Elucidating the enhanced binding affinity of a double mutant SP-D with trimannose on the influenza A virus using molecular dynamics.利用分子动力学阐明双突变体表面活性蛋白D与甲型流感病毒上的三甘露糖之间增强的结合亲和力。
Comput Struct Biotechnol J. 2022;20:4984-5000. doi: 10.1016/j.csbj.2022.08.045. Epub 2022 Sep 8.
9
Anti-inflammatory and anti-viral actions of anionic pulmonary surfactant phospholipids.阴离子肺表面活性剂磷脂的抗炎和抗病毒作用。
Biochim Biophys Acta Mol Cell Biol Lipids. 2022 Jun;1867(6):159139. doi: 10.1016/j.bbalip.2022.159139. Epub 2022 Feb 28.
10
Surfactant Protein-A Function: Knowledge Gained From SP-A Knockout Mice.表面活性蛋白A的功能:从表面活性蛋白A基因敲除小鼠获得的知识
Front Pediatr. 2022 Jan 7;9:799693. doi: 10.3389/fped.2021.799693. eCollection 2021.
具有中和呼吸道合胞病毒(RSV)功效的人肺表面活性蛋白A(SP-A)功能性三聚体片段的新型表达
Immunobiology. 2017 Feb;222(2):111-118. doi: 10.1016/j.imbio.2016.10.015. Epub 2016 Oct 18.
4
Complement in removal of the dead - balancing inflammation.补体在清除死亡细胞中的作用——平衡炎症。
Immunol Rev. 2016 Nov;274(1):218-232. doi: 10.1111/imr.12462.
5
Integrated Omics and Computational Glycobiology Reveal Structural Basis for Influenza A Virus Glycan Microheterogeneity and Host Interactions.整合组学与计算糖生物学揭示甲型流感病毒聚糖微异质性及宿主相互作用的结构基础。
Mol Cell Proteomics. 2016 Jun;15(6):1895-912. doi: 10.1074/mcp.M116.058016. Epub 2016 Mar 16.
6
Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein.通过纤维胶凝蛋白-1与糖蛋白(GP)粘蛋白结构域的相互作用增强埃博拉病毒感染
J Virol. 2016 May 12;90(11):5256-5269. doi: 10.1128/JVI.00232-16. Print 2016 Jun 1.
7
Surfactant Protein-D Is Essential for Immunity to Helminth Infection.表面活性蛋白-D对抵抗蠕虫感染的免疫至关重要。
PLoS Pathog. 2016 Feb 22;12(2):e1005461. doi: 10.1371/journal.ppat.1005461. eCollection 2016 Feb.
8
Airway Surfactant Protein D Deficiency in Adults With Severe Asthma.重度哮喘成人气道表面活性蛋白D缺乏症
Chest. 2016 May;149(5):1165-72. doi: 10.1016/j.chest.2015.11.012. Epub 2016 Jan 13.
9
Treatment and prophylaxis of influenza and the problem of resistance to neuraminidase inhibitors.流感的治疗与预防以及对神经氨酸酶抑制剂的耐药性问题
Postepy Hig Med Dosw (Online). 2015 Sep 20;69:1087-95.
10
Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.丙型肝炎病毒包膜糖蛋白E1在病毒粒子表面形成三聚体。
J Virol. 2015 Oct;89(20):10333-46. doi: 10.1128/JVI.00991-15. Epub 2015 Aug 5.